Cambridge Innovation Capital Launches £100M ($126M) Opportunity Fund to Back Later‑stage Deep Tech and Life Sciences

Deal Summary

Cambridge Innovation Capital (CIC) has launched a £100 million ($126M) Opportunity Fund anchored by Aviva Investors and British Patient Capital to invest up to £20M per deal in later‑stage deep tech and life sciences companies. Two portfolio companies cited are Pragmatic Semiconductor and Riverlane; the fund aims to address the U.K. later‑stage funding gap.